ARCHIVES

NIH to Review Intramural Program: NCI’s Intramural Spending is 17 Percent, Higher than 11.1 Percent NIH-Wide Level

This article is from The Cancer Letter archive.

Vol. 40 No. 10 | March 7, 2014

Download PDF Visit The Full Archive

Related Articles

New Test Predicts Breast Cancer Recurrence And Who Benefits Most From Chemotherapy

December 31, 2004

SBIR Priority Score Median Must Match R01s Under House Bill

June 28, 1996

Steven Woolf: Why CMS Should Not Cover LDCT

May 9, 2014

Study Finds Up To 12 Percent Of Specimens Misdiagnosed

October 28, 2005

NCI Unconventional Innovations Program releases Broad Agency Announcement.

October 24, 2003

NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial.

April 20, 2007